[Haematological effects of isoprodian (author's transl)].
D000328:Adult; D000368:Aged; D001769:Blood / Q000187:drug effects*; D001772:Blood Cell Count; D003622:Dapsone / Q000494:pharmacology* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology* / Q000627:therapeutic use; D007539:Isonicotinic Acids / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011515:Prothionamide / Q000494:pharmacology* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004338:Drug Combinations; D007539:Isonicotinic Acids; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid
Hämatologische Untersuchungen bei der Therapie der Tuberkulose mit dem Kombinationspräparat "Isoprodian"